Viewing Study NCT00394368


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-06-27 @ 9:53 PM
Study NCT ID: NCT00394368
Status: COMPLETED
Last Update Posted: 2020-08-03
First Post: 2006-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
Sponsor: Chiesi Farmaceutici S.p.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bronchial Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None asthma View
None combinations View
None inhaled therapy View
None corticosteroids View
None long acting bronchodilators View
None salmeterol View
None beclomethasone View
None formoterol View
None fluticasone View